Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective.
Britni Baxter, Shayla Sanders, Shilpa A Patel and 2 others
PMID 37406337WHAT IT FOUND
Infusion nurses should check serum uric acid before each pegloticase dose, stop treatment if levels stay above 6 mg/dL, monitor for reactions during and 1 hour after infusion, and counsel patients about flares and reporting symptoms.
Key findings
01Before each pegloticase infusion, the nurse reviews the serum uric acid level and notifies the prescriber if it is above 6 mg/dL; the protocol can discontinue treatment when levels stay high.
02The nurse monitors for infusion reactions during the infusion and for 1 hour after, and can slow or stop the infusion if a reaction occurs.
03In phase 3 monotherapy without a uric acid monitoring protocol, gout flares occurred in 77% and infusion reactions in 26% of patients.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review and educational article, not a controlled study, so it cannot show that the described nurse protocol prevents infusion reactions. The two cases are illustrative, not a trial, and one case stopped because uric acid remained above 6 mg/dL. The safety percentages come from cited phase 3 and extension studies, not from patients enrolled in this article. The article does not report a systematic search, how the case scenarios were selected, or whether they are real patients.
The easy way to misread this
Do not treat the improved case as proof that pegloticase plus methotrexate works for all patients. The article presents two illustrative scenarios, not a controlled trial, and one case stopped because serum uric acid stayed above 6 mg/dL.